ABSTRACT Background and Methods Although OBS is a well‐established approach, evidence regarding its long‐term safety and outcomes in older women remains limited. We performed a retrospective analysis to identify patients ≥ 60 years who underwent OBS for breast cancer between 2001 and 2014.
Francesca De Lorenzi +9 more
wiley +1 more source
Commentary: Characteristics of tertiary lymphoid structures in prostate cancer and the impact of neoadjuvant therapy on their formation and maturation. [PDF]
Wan Q +8 more
europepmc +1 more source
CX3CR1⁺ CD8⁺ cytotoxic T cells drive tumor killing in esophageal squamous cell carcinoma during neoadjuvant therapy. [PDF]
Zhao Y +12 more
europepmc +1 more source
Neoadjuvant Therapy in Locally Advanced Rectal Cancer-What Result Should We Expect? [PDF]
Stefan RE +11 more
europepmc +1 more source
Spatial Configuration of Pancreatic Cancer Is Associated with Disease Recurrence after Neoadjuvant Therapy and Curative-Intent Resection. [PDF]
Cisneros LH +18 more
europepmc +1 more source
Association of neoadjuvant therapy with locoregional recurrence according to recurrence definitions in breast cancer: a retrospective cohort study. [PDF]
Masuda Y +7 more
europepmc +1 more source
Comparative effectiveness of neoadjuvant therapy combined with stent placement versus stent alone in obstructive colorectal cancer: a multicenter retrospective analysis. [PDF]
Han Z +7 more
europepmc +1 more source
Neoadjuvant Therapy for Breast Cancer
Neoadjuvant treatment of breast cancer refers to the use of different treatment modalities prior to surgical excision of the tumor. It has been accepted as a treatment option for patients with nonmetastatic disease, because it renders inoperable tumors operable and increases the rates of breast-conserving surgery, while achieving similar long-term ...
Dimitrios, Zardavas, Martine, Piccart
openaire +3 more sources

